Now I have all the information needed. Let me produce the final consolidated review.

## Summary

This paper presents PaPaGei, the first openly released foundation model for PPG (photoplethysmography) signals, pre-trained on 57,641 hours of public data (20M segments from VitalDB, MIMIC-III, and MESA). The key methodological contribution is a morphology-aware self-supervised learning approach (PaPaGei-S) that uses sVRI-based contrastive pairing alongside IPA and SQI regression heads to capture richer PPG representations. The model is evaluated across 20 tasks spanning 10 datasets covering cardiovascular health, sleep disorders, pregnancy monitoring, and wellbeing. PaPaGei-S (5.7M parameters) achieves the best average AUROC (0.67) and MAE (10.12) compared to generic time-series foundation models (Chronos 200M, Moment 385M) and standard SSL methods (SimCLR, BYOL, TF-C), while being 35–70× smaller.

## Strengths

1. **Large-scale, openly released PPG foundation model pre-trained on public data.** The paper curates 57,641 hours / 20M segments from three public datasets (VitalDB, MIMIC-III, MESA) and commits to releasing model weights. This directly addresses a recognized gap where prior PPG models were either trained on proprietary data or not released, enabling reproducibility and downstream use by the community (Section 4.1, Table 1; contributions in Section 1).

2. **Morphology-aware SSL objective that outperforms standard contrastive methods.** PaPaGei-S uses sVRI-based positive pairing (treating signals with similar blood-volume-change morphology as positive pairs) plus IPA/SQI regression heads via mixture-of-experts (Section 3.2, Equations 1–4). It achieves higher average AUROC (0.67 vs. next best 0.64) and lower average MAE (10.12 vs. next best 10.65) than SimCLR, BYOL, and TF-C across all tasks (Tables 3 and 4), providing clear evidence that morphology-aware objectives capture more informative representations.

3. **Demonstrated out-of-domain generalization on diverse health tasks.** The evaluation covers 10 datasets including 7 unseen during pre-training (nuMom2B, VV, PPG-BP, SDB, ECSMP, WESAD, PPG-DaLiA), spanning pregnancy, sleep, cardiovascular, emotion, and wellbeing domains (Table 2). PaPaGei-S achieves best or competitive performance on out-of-domain tasks including SDB (0.70 AUROC), Hypertension (0.77), Systolic/Diastolic BP (VV and PPG-BP datasets), and AHI regression, providing concrete evidence of transfer beyond training domains.

4. **Parameter and data efficiency.** PaPaGei-S (5.7M parameters) outperforms Chronos (200M) and Moment (385M) on average metrics despite being 35–70× smaller (Table 3). Data-efficiency analysis (Figure 4) shows PaPaGei-S achieves lower MAE at both 25% and 100% labeled data, supporting applicability in resource-constrained clinical settings.

5. **Comprehensive ablation studies validating design choices.** Component ablations (Figure 5a–b) isolate contributions of sVRI, IPA, and SQI individually; pre-training data ablation (Figure 6) shows monotonic improvement with more data; scaling analysis (Figure 5c) demonstrates that the 5M model outperforms 35M and 139M variants, confirming smaller models are better suited for PPG data.

## Weaknesses

### Fatal
None.

### Major

1. **Subject-level overlap between pre-training and downstream evaluation for in-domain tasks (T1–T6).** The paper pre-trains PaPaGei on *all* subjects from VitalDB, MIMIC-III, and MESA (Section 4.1), then evaluates downstream performance on held-out test subjects drawn from the *same* datasets (T1–T2 from VitalDB, T3 from MIMIC-III, T4–T6 from MESA). The downstream split is subject-level with no overlap between train/val/test (Section 4.3), but pre-training used the entire dataset—including those test subjects. This means the model has already observed the raw signal of each in-domain test subject during pre-training, which can inflate downstream performance estimates, especially when subject-specific signal characteristics are predictive. The problem does not affect out-of-domain datasets (T7–T20, which constitute 14 of 20 tasks), but since the paper averages results across all 20 tasks and highlights these averages in its headline claims ("6.3% for classification, 2.9% for regression"), the in-domain contributions are contaminated. The authors would need to either (a) pre-train on a disjoint set of subjects for each in-domain dataset, or (b) present and headline results separately for in-domain vs. out-of-domain tasks. Without this correction, the claimed performance gains for the in-domain portion are not reliable.

2. **Missing results for multi-class classification tasks.** The task list (Table 2) includes Operation Type (T2, 9 classes) and Activity (T20, 9 classes), and the Methods section (Section 4.3) states that multi-class tasks are evaluated with accuracy via random forest. However, no multi-class results appear in the main results tables (Tables 3 and 4) or in the radar charts (which show AUROC and MAE only). Two of the 20 tasks are simply unaccounted for in the reported results, yet the paper claims evaluation across "20 tasks." These results must be reported and included in the aggregate metrics, or the paper should explicitly explain their exclusion.

### Minor

1. **Imprecise statistical comparison.** The paper claims PaPaGei "improves... in at least 14 tasks" but does not specify whether this means best overall, statistically significant improvement, or second-best, nor does it provide formal statistical tests (e.g., paired bootstrap tests) beyond reporting 95% CIs. Many confidence intervals overlap between PaPaGei-S and the best competitor on individual tasks (e.g., Mortality: PaPaGei-S 0.67 [0.63–0.70] vs. Chronos 0.68 [0.65–0.71]; Smoker: 0.61 vs. PaPaGei-P 0.64; Gestation Age: 6.05 vs. Chronos 5.69). A more rigorous comparison with explicit significance markings would strengthen the claims and give readers a clearer picture.

2. **Overclaimed "benchmark for bias evaluations."** The skin tone robustness analysis (Section 5.3, Figure 7) is limited to a single dataset (VV, 231 subjects) and a single task (blood pressure estimation). Describing this as "establishing a benchmark for bias evaluations of future models" (abstract) is disproportionate. It is better described as a preliminary investigation that usefully surfaces the issue but requires multiple datasets, tasks, and annotation schemes to constitute a benchmark.

3. **No sensitivity analysis for sVRI binning.** The sVRI discretization uses 8 bins without any sensitivity analysis or justification for this choice. Since the binning directly defines positive pairs in the contrastive objective, the results could be sensitive to this hyperparameter. A robustness check (e.g., varying the number of bins) would strengthen confidence in the method.

### Trivial

None that survive filtering (parser artifacts and formatting issues are excluded per instructions).

## Nice-to-Haves

- **Data-efficiency analysis with a non-pre-trained PaPaGei-S baseline.** The data-efficiency experiment (Figure 4) compares PaPaGei-S against TF-C and Moment, but including a version of PaPaGei-S trained *without* pre-training (random initialization) would isolate the benefit of pre-training from the benefit of the SSL architecture itself, strengthening the contribution.

- **Inference-time computational cost analysis.** The paper claims suitability for "resource-constrained medical environments" and on-device deployment (Section 6). Reporting latency, FLOPs, or memory footprint would substantiate this claim.

- **Error or failure case analysis.** For a paper targeting clinical applications, discussion of when the model fails (e.g., noisy signals, extreme physiological values, specific subpopulations) would add practical depth.

## Removed Points

- **Criticism that REGLE contradicts the "first open foundation model" claim.** The paper acknowledges REGLE as a pre-trained PPG model (Yun 2024) used as a baseline. REGLE has 0.07M parameters (vs. PaPaGei's 5.7M) and the paper's claim is about releasing weights openly. Without external verification of REGLE's release status and given the paper's own citation of it, this criticism is not actionable here. Removed per Hard Rules disallowing questioning of cited entities' existence/release status.

- **Criticism about sVRI formula differing from cited papers.** The reviewer claims sVRI is defined differently in the cited works (Lyu 2015, Zhang 2019). The paper clearly presents its own formula in Equation (1). Without access to the cited papers to verify, this cannot be confirmed. Removed per Hard Rules.

- **Criticism about unspecified "unfair comparison."** The reviewer's suggestion that comparison asymmetry favors baselines is not substantiated; the paper uses standard SSL methods (SimCLR, BYOL, TF-C) with recommended architectures. Removed as unsubstantiated.

- **Generic formatting/style nitpicks.** Removed per Hard Rules.

## Novel Insights

The most interesting observation emerging from these reviews—beyond the paper's own claims—is a point about the scaling dynamics of physiological foundation models. The paper's scaling analysis (Figure 5c) shows that the 5M model consistently outperforms 35M and 139M variants, which the paper attributes to PPG data being well-suited to smaller architectures. This is unusual compared to language and vision domains where scaling almost always helps, and it raises an important open question for the community: do physiological signals have a fundamentally lower "intrinsic dimension" than natural signals, such that larger models simply overfit to noise? This observation, if validated more broadly, could substantially influence research priorities in biomedical foundation modeling toward architectural innovation over brute-force scaling.

## Suggestions

1. **Address the pre-training contamination issue** by either (a) re-running pre-training with a subject-level holdout for VitalDB, MIMIC-III, and MESA, or (b) prominently separating in-domain vs. out-of-domain results and not including contaminated in-domain results in headline averages. Compare the corrected results with current results to quantify any inflation.

2. **Report the missing multi-class classification results** (T2: Operation Type, T20: Activity) with accuracy metrics and include them in all aggregate summaries.

3. **Replace the vague "14 tasks" claim** with a table or figure explicitly marking which comparisons achieve statistical significance (e.g., non-overlapping 95% CIs or p < 0.05 from paired bootstrap tests).

4. **Add a random-initialization baseline** to the data-efficiency analysis to separate the effect of pre-training from the effect of the SSL architecture.

5. **Tone down the "benchmark for bias evaluations" language** or run the skin tone analysis on additional datasets and tasks.

## Score and Decision

MY FINAL SCORE: <pineapple>6.0</pineapple>
MY FINAL DECISION: <orange>Weak Accept</orange>